GAS5 and breast cancer: Several studies have demonstrated that GAS5 is down-regulated in gastric [35], glioma [36], stomach [37], lung [38], cervical [39], liver [40], gallbladder [41], pancreatic [42], prostate [43] and breast cancer [13].